Patents by Inventor Noriko IWAMOTO
Noriko IWAMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250102515Abstract: A sample preparation kit provides a significantly versatile analytical technique that is not affected by the diversity of antibodies, difference in species, matrix and the like. For preparing a sample to be used for detection of a monoclonal antibody through high-performance liquid chromatography-mass spectrometry (LC-MS), the kit includes a porous body for immobilizing a monoclonal antibody to be detected; nanoparticles with an immobilized protease; a reaction vessel for selectively digesting the monoclonal antibody by bringing the porous body and nanoparticles into contact; a buffer to be introduced into the reaction vessel along with the nanoparticles and porous body so that a protease reaction is carried out; and a filtration membrane to remove the porous body and nanoparticles after the proteolysis so as to extract the reaction product and the buffer.Type: ApplicationFiled: December 10, 2024Publication date: March 27, 2025Applicant: SHIMADZU CORPORATIONInventors: Takashi SHIMADA, Noriko IWAMOTO
-
Patent number: 12216126Abstract: A sample preparation kit related to the present invention provides a significantly versatile analytical technique that is not affected by the diversity of antibodies, difference in species, matrix and the like. For preparing a sample to be used for detection of a monoclonal antibody through high-performance liquid chromatography-mass spectrometry (LC-MS), the kit includes a porous body for immobilizing a monoclonal antibody to be detected; nanoparticles with an immobilized protease; a reaction vessel for selectively digesting the monoclonal antibody by bringing the porous body and nanoparticles into contact; a buffer to be introduced into the reaction vessel along with the nanoparticles and porous body so that a protease reaction is carried out; and a filtration membrane to remove the porous body and nanoparticles after the proteolysis so as to extract the reaction product and the buffer.Type: GrantFiled: November 16, 2021Date of Patent: February 4, 2025Assignee: SHIMADZU CORPORATIONInventors: Takashi Shimada, Noriko Iwamoto
-
Patent number: 12188942Abstract: The present invention provides a detection method for a monoclonal antibody in a sample, comprising: (a) a step of capturing the monoclonal antibody in the sample and immobilizing the monoclonal antibody in pores of a porous body; (b) a step of bringing the porous body in which the monoclonal antibody is immobilized with nanoparticles on which protease is immobilized to conduct selective protease digestion of the monoclonal antibody; (c) a step of detecting, by a liquid chromatography mass spectrometry (LC-MS), peptide fragments obtained by the selective protease digestion; and (a?) a step of conducting a reduction reaction under an acidic condition after the step (a). By the present invention, further applicability of the detection method for the monoclonal antibodies using mass spectrometry is expected.Type: GrantFiled: December 28, 2017Date of Patent: January 7, 2025Assignee: SHIMADZU CORPORATIONInventors: Noriko Iwamoto, Takashi Shimada
-
Publication number: 20240385199Abstract: A method is provided that allows for antibody quantification with mass spectrometry without creating a calibration curve using an antibody of interest. An antibody analysis method is provided, including: digesting a biological protein and a target antibody with a protease; performing mass spectrometry of peptide fragments of the biological protein and the target antibody obtained by the digesting; quantifying the target antibody based on a ratio between a detected intensity of the biological protein and a detected intensity of the target antibody obtained by the mass spectrometry, the digesting with a protease including: immobilizing the biological protein and the target antibody inside pores of a support; bringing a microparticle close to the support, the microparticle having a diameter larger than a diameter of the pores and having a surface to which a protease is immobilized, wherein the biological protein has a domain capable of being immobilized inside the pores.Type: ApplicationFiled: April 8, 2022Publication date: November 21, 2024Applicant: Shimadzu CorporationInventors: Takashi SHIMADA, Noriko IWAMOTO
-
Publication number: 20240345096Abstract: A method of identifying an unknown spliced peptide derived from a known parent peptide contained in a biological sample, the method comprising: (1) a first step involving performing mass spectrometry on the sample to obtain mass spectrometry data regarding a peptide contained in the sample; (2) a second step involving searching a primary library, which is a database of known amino acid sequences, for an amino acid sequence that matches the mass spectrometry data, to identify a parent peptide contained in the sample, (3) a third step involving creating a secondary library including a candidate group of spliced peptides obtainable from the identified parent peptide; and (4) a fourth step involving searching the secondary library for an amino acid sequence that matches the mass spectrometry data, to identify a spliced peptide contained in the sample.Type: ApplicationFiled: July 22, 2022Publication date: October 17, 2024Applicants: Providence Health & Services-Oregon, Shimadzu CorporationInventors: Yoshinobu Koguchi, Noriko IWAMOTO, Takashi SHIMADA
-
Patent number: 11650210Abstract: A method of proteolyzing a protein, including immobilizing a protein in at least one pore of a porous body, and contacting the protein immobilized in the pore and a protease immobilized on a solid surface such that the protease selectively accesses a site of the protein and proteolyzes the protein at the site.Type: GrantFiled: April 15, 2021Date of Patent: May 16, 2023Assignee: SHIMADZU CORPORATIONInventors: Takashi Shimada, Noriko Iwamoto, Chikage Aoki, Taka-Aki Sato
-
Patent number: 11619616Abstract: The present invention provides a method in which a porous body having a monoclonal antibody to be measured immobilized in pores thereof is brought into contact with nanoparticles having a protease immobilized thereonto in a liquid to perform selective protease digestion of the monoclonal antibody and a peptide fragment obtained by the digestion is detected by liquid chromatography mass spectrometry (LC-MS), wherein the monoclonal antibody is digested with the protease in the presence of an antibody specifically binding to the monoclonal antibody or a target molecule of the monoclonal antibody.Type: GrantFiled: June 22, 2017Date of Patent: April 4, 2023Assignee: SHIMADZU CORPORATIONInventors: Noriko Iwamoto, Takashi Shimada
-
Patent number: 11446653Abstract: A container set including: a filter unit; and a closing unit that is attachable to and detachable from the filter unit. The filter unit includes: a housing having a sample introduction opening provided at one end, and a liquid discharging opening provided at the second end; and a filter fixed to the housing. The housing has a first joining part, and the closing unit has a second joining part configured to be joinable with the first joining part. The first joining part and the second joining part are configured such that the liquid discharging opening is spatially closed in a state in which the two joining parts are joined together. A space between the closing unit and the filter is made into a positive pressure relative to a pressure in the sample holding space by pushing the filter unit and the closing unit such that the distance therebetween is shortened.Type: GrantFiled: June 30, 2016Date of Patent: September 20, 2022Assignee: SHIMADZU CORPORATIONInventors: Noriko Iwamoto, Megumi Takanashi, Takashi Shimada
-
Publication number: 20220137062Abstract: A sample preparation kit related to the present invention provides a significantly versatile analytical technique that is not affected by the diversity of antibodies, difference in species, matrix and the like. For preparing a sample to be used for detection of a monoclonal antibody through high-performance liquid chromatography-mass spectrometry (LC-MS), the kit includes a porous body for immobilizing a monoclonal antibody to be detected; nanoparticles with an immobilized protease; a reaction vessel for selectively digesting the monoclonal antibody by bringing the porous body and nanoparticles into contact; a buffer to be introduced into the reaction vessel along with the nanoparticles and porous body so that a protease reaction is carried out; and a filtration membrane to remove the porous body and nanoparticles after the proteolysis so as to extract the reaction product and the buffer.Type: ApplicationFiled: November 16, 2021Publication date: May 5, 2022Applicant: SHIMADZU CORPORATIONInventors: Takashi SHIMADA, Noriko IWAMOTO
-
Patent number: 11209392Abstract: The present invention provides a method for detecting a monoclonal antibody in a sample, the method comprising: (a) a step of capturing and immobilizing, in pores of a porous body, the monoclonal antibody in the sample; (b) a step of performing selective protease digestion of the monoclonal antibody for 30 min or longer by contacting the porous body having the monoclonal antibody immobilized thereon with nanoparticles having a protease immobilized thereon; and (c) a step of detecting a peptide fragment obtained by the selective protease digestion, using liquid chromatography mass spectrometry (LC-MS), wherein step (b) is carried out under stirring condition for 10 sec to 5 min in the initial reaction stage, and then under static condition. According to the present invention, the detection method of a monoclonal antibody using mass spectrometry is simplified and can be applicable to multisample analysis.Type: GrantFiled: December 28, 2017Date of Patent: December 28, 2021Assignee: Shimadzu CorporationInventors: Takashi Shimada, Noriko Iwamoto, Megumi Takanashi
-
Publication number: 20210332108Abstract: The method according to the present invention for preparing peptide fragments comprises bringing an antibody, which includes a Fc domain immobilized in pores of a porous body, into contact with a protease immobilized on surface of microparticles. Thus, the Fab domain of the antibody is site-specifically cleaved by the protease and a sample containing Fab domain-derived peptide fragments at a high concentration can be obtained. The protease to be used in the present invention is an animal-derived trypsin contaminated with chymotrypsin wherein the chymotrypsin is inactivated and the trypsin is chemically modified at amino group in lysine residues.Type: ApplicationFiled: August 3, 2016Publication date: October 28, 2021Applicant: SHIMADZU CORPORATIONInventors: Takashi SHIMADA, Noriko IWAMOTO, Chikage AOKI
-
Publication number: 20210263044Abstract: A method of proteolyzing a protein, including immobilizing a protein in at least one pore of a porous body, and contacting the protein immobilized in the pore and a protease immobilized on a solid surface such that the protease selectively accesses a site of the protein and proteolyzes the protein at the site.Type: ApplicationFiled: April 15, 2021Publication date: August 26, 2021Applicant: SHIMADZU CORPORATIONInventors: Takashi SHIMADA, Noriko IWAMOTO, Chikage AOKI, Taka-Aki SATO
-
Publication number: 20210215690Abstract: The present invention provides a method for detecting a monoclonal antibody in a sample, comprising: (a) a step of capturing the monoclonal antibody in the sample and immobilizing the monoclonal antibody in pores of a porous body; (b) a step of bringing the porous body in which the monoclonal antibody is immobilized with nanoparticles on which protease is immobilized to conduct selective protease digestion of the monoclonal antibody; and (c) a step of detecting, by a liquid chromatography mass spectrometry (LC-MS), peptide fragments obtained by the selective protease digestion, wherein the selective protease digestion of step (b) is conducted at pH 8 to 9 in the presence of a chaotropic reagent and a reducing agent.Type: ApplicationFiled: February 8, 2018Publication date: July 15, 2021Applicant: SHIMADZU CORPORATIONInventors: Takashi SHIMADA, Noriko IWAMOTO
-
Patent number: 11022616Abstract: A method of proteolyzing a protein, including immobilizing a protein in at least one pore of a porous body, and contacting the protein immobilized in the pore and a protease immobilized on a solid surface such that the protease selectively accesses a site of the protein and proteolyzes the protein at the site.Type: GrantFiled: November 14, 2019Date of Patent: June 1, 2021Assignee: SHIMADZU CORPORATIONInventors: Takashi Shimada, Noriko Iwamoto, Chikage Aoki, Taka-Aki Sato
-
Publication number: 20210055188Abstract: Certain embodiments are directed to methods for preparing or processing FFPE samples for subsequent analysis of antibodies or other proteins contained within the FFPE sample. In certain aspects, preparing or processing a FFPE sample can include, but is not limited to (i) deparaffinizing a portion of the FFPE specimen, (ii) decrosslinking the deparaffinized sample portion, (iii) homogenizing the decrosslinked portion, and (iv) fractionating the homogenized portion, wherein isolated antibodies or proteins having a higher order structure that can be bound by capture agents, e.g., immunoglobulin capture agents.Type: ApplicationFiled: July 27, 2020Publication date: February 25, 2021Inventors: Noriko IWAMOTO, Takashi SHIMADA
-
Publication number: 20210003587Abstract: The present invention provides a detection method for a monoclonal antibody in a sample, comprising: (a) a step of capturing the monoclonal antibody in the sample and immobilizing the monoclonal antibody in pores of a porous body; (b) a step of bringing the porous body in which the monoclonal antibody is immobilized with nanoparticles on which protease is immobilized to conduct selective protease digestion of the monoclonal antibody; (c) a step of detecting, by a liquid chromatography mass spectrometry (LC-MS), peptide fragments obtained by the selective protease digestion; and (a?) a step of conducting a reduction reaction under an acidic condition after the step (a). By the present invention, further applicability of the detection method for the monoclonal antibodies using mass spectrometry is expected.Type: ApplicationFiled: December 28, 2017Publication date: January 7, 2021Applicant: SHIMADZU CORPORATIONInventors: Noriko IWAMOTO, Takashi SHIMADA
-
Publication number: 20200309735Abstract: The present invention provides a method for detecting a monoclonal antibody in a sample, the method comprising: (a) a step of capturing and immobilizing, in pores of a porous body, the monoclonal antibody in the sample; (b) a step of performing selective protease digestion of the monoclonal antibody for 30 min or longer by contacting the porous body having the monoclonal antibody immobilized thereon with nanoparticles having a protease immobilized thereon; and (c) a step of detecting a peptide fragment obtained by the selective protease digestion, using liquid chromatography mass spectrometry (LC-MS), wherein step (b) is carried out under stirring condition for 10 sec to 5 min in the initial reaction stage, and then under static condition. According to the present invention, the detection method of a monoclonal antibody using mass spectrometry is simplified and can be applicable to multisample analysis.Type: ApplicationFiled: December 28, 2017Publication date: October 1, 2020Applicant: Shimadzu CorporationInventors: Takashi Shimada, Noriko Iwamoto, Megumi Takanashi
-
Publication number: 20200306748Abstract: A container set including: a filter unit; and a closing unit that is attachable to and detachable from the filter unit. The filter unit includes: a housing having a sample introduction opening provided at one end, and a liquid discharging opening provided at the second end; and a filter fixed to the housing. The housing has a first joining part, and the closing unit has a second joining part configured to be joinable with the first joining part. The first joining part and the second joining part are configured such that the liquid discharging opening is spatially closed in a state in which the two joining parts are joined together. A space between the closing unit and the filter is made into a positive pressure relative to a pressure in the sample holding space by pushing the filter unit and the closing unit such that the distance therebetween is shortened.Type: ApplicationFiled: June 30, 2016Publication date: October 1, 2020Applicant: Shimadzu CorporationInventors: Noriko IWAMOTO, Megumi TAKANASHI, Takashi SHIMADA
-
Publication number: 20200173960Abstract: The present invention provides a method in which a porous body having a monoclonal antibody to be measured immobilized in pores thereof is brought into contact with nanoparticles having a protease immobilized thereonto in a liquid to perform selective protease digestion of the monoclonal antibody and a peptide fragment obtained by the digestion is detected by liquid chromatography mass spectrometry (LC-MS), wherein the monoclonal antibody is digested with the protease in the presence of an antibody specifically binding to the monoclonal antibody or a target molecule of the monoclonal antibody.Type: ApplicationFiled: June 22, 2017Publication date: June 4, 2020Applicant: Shimadzu CorporationInventors: Noriko Iwamoto, Takashi Shimada
-
Publication number: 20200011876Abstract: The present invention provides a technique that can simultaneously analyze a plurality of antibody drugs and can be validated. The present invention provides a method of bringing a porous body in which monoclonal antibodies to be measured are immobilized in pores into contact in a liquid with nanoparticles on which proteases are immobilized and performing selective proteolysis of monoclonal antibodies to detect peptide fragments each comprising unique amino acid sequence derived from the Fab region of the monoclonal antibodies via liquid chromatography-mass spectrometry (LC-MS), wherein peptide fragments of two or more types of monoclonal antibodies in the same biological sample are simultaneously quantified.Type: ApplicationFiled: March 14, 2017Publication date: January 9, 2020Applicant: Shimadzu CorporationInventors: Noriko Iwamoto, Megumi Takanashi, Takashi Shimada